ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Avidity Biosciences Inc

Avidity Biosciences Inc (RNA)

31.82
0.77
(2.48%)
Closed 22 December 8:00AM
31.8195
-0.0005
(0.00%)
After Hours: 11:59AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
31.82
Bid
30.00
Offer
47.00
Volume
2,932,040
30.85 Day's Range 32.63
8.37 52 Week Range 56.00
Market Cap
Previous Close
31.05
Open
30.92
Last Trade
33
@
31.51
Last Trade Time
Financial Volume
US$ 92,249,892
VWAP
31.4627
Average Volume (3m)
1,087,400
Shares Outstanding
119,309,317
Dividend Yield
-
PE Ratio
-17.89
Earnings Per Share (EPS)
-1.78
Revenue
9.56M
Net Profit
-212.22M

About Avidity Biosciences Inc

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Avidity Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNA. The last closing price for Avidity Biosciences was US$31.05. Over the last year, Avidity Biosciences shares have traded in a share price range of US$ 8.37 to US$ 56.00.

Avidity Biosciences currently has 119,309,317 shares in issue. The market capitalisation of Avidity Biosciences is US$3.70 billion. Avidity Biosciences has a price to earnings ratio (PE ratio) of -17.89.

Avidity Biosciences (RNA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-622k

Calls / Puts

40.00%

Buys / Sells

50.00%

OTM / ITM

40.00%

Sweeps Ratio

0.00%

RNA Latest News

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Dec. 20, 2024 SAN DIEGO, Dec. 20, 2024 /PRNewswire/ -- Avidity Biosciences, Inc...

Avidity Biosciences to Participate in Upcoming Investor Conference

Avidity Biosciences to Participate in Upcoming Investor Conference PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a...

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Nov. 21, 2024 SAN DIEGO, Nov. 21, 2024 /PRNewswire/ --Β Avidity Biosciences, Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.79-5.3257958940833.6134.7830.07165641931.95957227CS
4-10.74-25.23496240642.5645.9830.07126025036.92482601CS
12-10.57-24.93512620942.395630.07108740042.69039529CS
26-6.24-16.395165528138.065630.07130736243.00008809CS
5222.76251.2141280359.06568.37126699233.33563102CS
1568.6537.332757876623.17564.825101860722.06642835CS
2605.3220.075471698126.5564.82576781122.44942189CS

RNA - Frequently Asked Questions (FAQ)

What is the current Avidity Biosciences share price?
The current share price of Avidity Biosciences is US$ 31.82
How many Avidity Biosciences shares are in issue?
Avidity Biosciences has 119,309,317 shares in issue
What is the market cap of Avidity Biosciences?
The market capitalisation of Avidity Biosciences is USD 3.7B
What is the 1 year trading range for Avidity Biosciences share price?
Avidity Biosciences has traded in the range of US$ 8.37 to US$ 56.00 during the past year
What is the PE ratio of Avidity Biosciences?
The price to earnings ratio of Avidity Biosciences is -17.89
What is the cash to sales ratio of Avidity Biosciences?
The cash to sales ratio of Avidity Biosciences is 397.25
What is the reporting currency for Avidity Biosciences?
Avidity Biosciences reports financial results in USD
What is the latest annual turnover for Avidity Biosciences?
The latest annual turnover of Avidity Biosciences is USD 9.56M
What is the latest annual profit for Avidity Biosciences?
The latest annual profit of Avidity Biosciences is USD -212.22M
What is the registered address of Avidity Biosciences?
The registered address for Avidity Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Avidity Biosciences website address?
The website address for Avidity Biosciences is www.aviditybiosciences.com
Which industry sector does Avidity Biosciences operate in?
Avidity Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

RNA Discussion

View Posts
Whalatane Whalatane 1 month ago
Gr8 day and clean technical breakout ( for those that follow such things )
Kiwi
πŸ‘οΈ0
harry crumb harry crumb 1 month ago
Agree we have been in for awhike now
πŸ‘οΈ0
Whalatane Whalatane 3 months ago
Impressive fireside presentation . Still years away from an approved drug but likely to seek accelerated path .
Rare diseases only require one pivotal trial ...and their trial don't require biopsies...so easier to enroll .
2 yr safety data looks good
Potential multi billion $ markets
Kiwi
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
RNA almost a ten bagger
πŸ‘οΈ0
harry crumb harry crumb 5 months ago
50 this week $$$$$$$
πŸ‘οΈ0
harry crumb harry crumb 5 months ago
50 is almost fact! $$$$$$
πŸ‘οΈ0
harry crumb harry crumb 5 months ago
Almost folks, what a run! $$$$$$$
πŸ‘οΈ0
harry crumb harry crumb 5 months ago
Will sell some teens at 50$, mega profits $$$$$$
πŸ‘οΈ0
harry crumb harry crumb 6 months ago
Complete beast, 50 may be sooner than expected
πŸ‘οΈ0
harry crumb harry crumb 6 months ago
Boom!
πŸ‘οΈ0
harry crumb harry crumb 6 months ago
Chart still in an upward spiral $$$$$
πŸ‘οΈ0
harry crumb harry crumb 7 months ago
Beast just a beast from 8.00! Wow
πŸ‘οΈ0
harry crumb harry crumb 7 months ago
Wow!
πŸ‘οΈ0
harry crumb harry crumb 7 months ago
Beast an enough said $$$$$
πŸ‘οΈ0
harry crumb harry crumb 8 months ago
Moving up again, rna is a winner folks
πŸ‘οΈ0
harry crumb harry crumb 8 months ago
Nothing but up! $$$$$
πŸ‘οΈ0
harry crumb harry crumb 8 months ago
Beast $$$$$
πŸ‘οΈ0
harry crumb harry crumb 9 months ago
Loaded 10-10-50’s, sold half here… $$$$$, it has been on a tear my friends, don’t get greedy lol
πŸ‘οΈ0
harry crumb harry crumb 9 months ago
Double beast
πŸ‘οΈ0
harry crumb harry crumb 9 months ago
Beast here
πŸ‘οΈ0
harry crumb harry crumb 10 months ago
Called it, 20’s are in, 23.80 tough break, we’l see
πŸ‘οΈ0
harry crumb harry crumb 10 months ago
6.25-7 buys are making wealth! Beautiful chart moving forward $$$$$
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
It’l b 20+ again, soon
πŸ‘οΈ0
novicetrader novicetrader 1 year ago
Any idea why this popped yesterday on heavy volume,any rumors/talk? This is a keeper for sure, wondering why it jumped yesterday.
πŸ‘οΈ0
Gatorhide Gatorhide 1 year ago
Yes sir.
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
This will be 15 in a matter of time, something huge brewing an bms knows it, they are in on it now. Buy now an hold. Loading zone imo $$$$$$
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
6.85 WTF MEANWHILE HNRA GOING UP^UP

AND RDHL HALTED UP


GRRRRRRRRR
πŸ‘οΈ0
Jess070283 Jess070283 1 year ago
My pick for the day. Loading up. IMO
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Boom, ya just never know with bio’s! $$$$$$$$$,
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Insiders are buying something is coming, 20+ again, we shall see
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
8.90’s was the floor. Lets see this back to 20, wwweeeeee $$$$$
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Wow, haven’t been following this, under 11.00, this was recently 25.00 stock, shorting should be illegal, poor souls who entered this in the 20’s have been lefted!
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
With some superb news we see 30’s very fast here, in this for the long haul, have patience
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
No u wont
πŸ‘οΈ0
OmegaMoney29 OmegaMoney29 2 years ago
Looks trashy. I will short this dead trash all day tomorrow. Watch out. This is trash trash trash. Haahahahhahaha ooooooooooooiooooof
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Back in long, reversal will happen
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Buy an hold, wow opportunity of wealth again here
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
What power here
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Sold the high 22’s, this may get shorted back to the 14/15’s on the long wait for their sciences
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
17.25 buy long!
πŸ‘οΈ0
Justfactsmam Justfactsmam 2 years ago
Great interim trial news... so shorting RNA is a time bomb... Lifting hold on new candidates in the current trial will add $10 to stock without squeeze...likely a double SP on the news with the aid of with flippers like you chasing to cover... make my day!
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
This stock right now is a flippers dream, wild swings, getting in an out makes u money.
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Long way to go to get anywhere clise to moderna my friend, a long long way. 5 yrs minimum if this science even gets to ph 3
πŸ‘οΈ0
dinogreeves dinogreeves 2 years ago
Where have you been collecting your bread crumbs, this company has over 400 million dollars in the coffers, that is why the stock is behaving like it is. The next Moderna.
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Stock offering/dilution, let it drop, shorting this is money!, at least for now. We’l buy long after all the shares settle down. Plenty shares to short now. Money made easy here
πŸ‘οΈ0
Pt3 Pt3 2 years ago
No more mrna
πŸ‘οΈ0
dinogreeves dinogreeves 2 years ago
The next Moderna in the making. Boom
πŸ‘οΈ0
stocktrademan stocktrademan 10 years ago
$RNA DD Notes ~ http://www.ddnotesmaker.com/RNA

bullish

$RNA recent news/filings

## source: finance.yahoo.com

Fri, 17 Oct 2014 22:03:19 GMT ~ Nasdaq stocks posting largest percentage increases


read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************

Wed, 15 Oct 2014 12:19:06 GMT ~ Prosensa (RNA) Shares March Higher, Can It Continue?


read full: http://finance.yahoo.com/news/prosensa-rna-shares-march-higher-121906240.html
*********************************************************

Tue, 14 Oct 2014 10:31:16 GMT ~ Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5%


read full: http://finance.yahoo.com/news/prosensa-holding-n-v-rna-103116677.html
*********************************************************

Mon, 13 Oct 2014 20:30:02 GMT ~ Prosensa Starts Rolling NDA Submission for Drisapersen


read full: http://finance.yahoo.com/news/prosensa-starts-rolling-nda-submission-203002061.html
*********************************************************

Mon, 13 Oct 2014 16:29:00 GMT ~ Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study


read full: http://www.thestreet.com/story/12911313/1/sarepta-drug-could-benefit-from-duchenne-muscular-dystrophy-patient-study.html?puc=yahoo&cm_ven=YAHOO
*********************************************************


$RNA charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$RNA company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/RNA/company-info
Ticker: $RNA
OTC Market Place: Not Available
CIK code: not found
Company name: Prosensa Holding N.V.
Incorporated In:

Business Description:


$RNA share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$RNA extra dd links

Company name: Prosensa Holding N.V.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RNA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RNA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RNA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RNA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RNA+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/news - http://finance.yahoo.com/q/h?s=RNA+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RNA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RNA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RNA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RNA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RNA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RNA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Prosensa+Holding+N.V.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Prosensa+Holding+N.V.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Prosensa+Holding+N.V.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RNA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RNA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RNA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RNA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RNA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RNA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RNA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RNA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RNA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RNA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RNA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RNA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RNA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RNA+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RNA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RNA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RNA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RNA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RNA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RNA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RNA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RNA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RNA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RNA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RNA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RNA



$RNA DD Notes ~ http://www.ddnotesmaker.com/RNA
πŸ‘οΈ0
maytepper maytepper 10 years ago
$RNA Roth Capital Sees 93% Upside In Prosensa But Financial Overhang Still Exist http://www.smarteranalyst.com/2014/09/19/roth-capital-sees-93-upside-prosensa-financial-overhang-still-exist/
πŸ‘οΈ0
maytepper maytepper 10 years ago
$RNA Roth Capital Upgrades Prosena To Buy, Sees %175 Upside For The Stock http://www.smarteranalyst.com/2014/07/29/roth-capital-upgrades-prosena-to-buy-sees-5-upside-for-the-stock/
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock